A Step Closer to Closure in Bioprocessing
As biopharma anticipates the “Facility of the Future,” a definition of what closed processing is, and quantification of its value, can be helpful information.
The Patient-Centric Manufacturing Model
Jason Bock, co-founder and CEO of CTMC, discusses the industry impact and manufacture of patient-centered medicines.
Quality Pitfalls of Aging Facilities and Equipment
Operating in an aging facility and/or utilizing outdated equipment may lead to drug shortages and high operating costs.
How Modularization and Digital Delivery are Transforming Pharma Manufacturing
Modular and replication strategies are being utilized to meet growing demand for CDMO facilities.
Extracellular Vesicles and Fluorescence Excitation-Emission Matrix Spectroscopy
Fluorescence spectroscopy offers unique advantages for characterizing EVs.
